news, journals and articles from all over the world.
ECS is proud to announce that the 240th ECS Meeting will take place at the Orange County Convention Center in Orlando, FL, from October 10-14, 2021. The Electrochemistry in Space Symposium is a highlight of the meeting, among other events. Learn more!
Read moreObamacare will get retooled, not repealed. A national mask mandate will boost consumer spending, research shows (though don’t expect much from homeowners, they’re strapped). The $300 billion for R&D should go to D, not R. So forecasts an array of WashU experts.
Read more
Each corn harvest leaves behind leaves, husks and cobs. Research shows cattle can take advantage of this food resource without damaging field productivity.
Read moreTexas Biomedical Research Institute (Texas Biomed) in San Antonio, Texas, was awarded $1 million from the Bill & Melinda Gates Foundation to test the efficacy of human monoclonal antibodies (MAbs) for the treatment of SARS-CoV-2 infection. MAbs are human-made proteins meant to mimic human immune system antibodies. Texas Biomed Professors Luis Martinez-Sobrido, Ph.D. and Jordi B. Torrelles, Ph.D. will co-lead the project to evaluate the protective efficacy of these MAbs in small rodent models, developed at Texas Biomed, on behalf of the Coronavirus Immunotherapy Consortium (CoVIC), an international nonprofit consortium evaluating MAb therapeutics for COVID-19.
Read more
Baylor Scott & White Health, the largest not-for-profit health system in the state of Texas, today announces two separate academic affiliations: a new affiliation with Baylor College of Medicine and an expanded affiliation with their long-time partner Texas A&M University. Both alliances are aimed at training future clinicians and developing programs that advance high-quality care and healthcare innovation.
Read more
Earlier this month, Baylor Scott & White Research Institute enrolled the first four patients in the world on Gilead’s new clinical trial involving an investigational inhaled solution of remdesivir (NCT04539262). This is Gilead’s first trial in COVID-19 patients examining the safety and efficacy of an inhaled solution of the drug in an outpatient setting. The study of an inhaled solution asks whether this mode of delivery can help reduce the amount of virus from the airways earlier.
Read moreThe University of Chicago Medicine is launching a clinical trial to examine the potential of an antibody against the SARS-CoV-2 spike protein for treating COVID-19, the disease caused by the novel coronavirus.
Read moreThe Israel – U.S. Binational Industrial Research and Development (BIRD) Foundation announced it is seeking proposals for collaborative projects to develop advanced technologies for the homeland security mission.
Read more
Researchers have developed a technology called “Artificial Chemist,” which incorporates artificial intelligence and an automated system for performing chemical reactions to accelerate R&D and manufacturing of commercially desirable materials.
Read more
Men who tested positive for COVID-19 are now being enrolled in a unique study led by the University of Miami Miller School of Medicine to determine the interaction of the virus with semen.
Read moreThis release concerns conclusive results from a research project that was put together to model the potential spread of coronavirus through air particles in indoor public spaces such as supermarkets (https://www.aalto.fi/en/news/researchers-modelling-the-spread-of-the-coronavirus-emphasise-the-importance-of-avoiding-busy)
Read more
For COVID-19 patients in severe respiratory distress, the University of Miami Miller School of Medicine now offers access to mesenchymal
Read more